Clinical trials
Completed Phase 4 Multiple Sclerosis, Relapsing-Remitting trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 5 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 2 |
| 2017 | 3 |
| 2019 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 45 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 14 |
| Novartis Pharmaceuticals | 10 |
| Merck KGaA, Darmstadt, Germany | 4 |
| Bayer | 2 |
| EMD Serono | 2 |
| Genzyme, a Sanofi Company | 2 |
| University Hospital Muenster | 2 |
| Claudio Gobbi | 1 |
| Coordinación de Investigación en Salud, Mexico | 1 |
| Cornerstone Health Care, PA | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 45 |
| Multiple Sclerosis | 18 |
| Anxiety Disorders | 1 |
| Flushing | 1 |
| Memory Disorders | 1 |
| Neurobehavioral Manifestations | 1 |
| Vitamin D Deficiency | 1 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.